Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells()

BRAF is the most frequently mutated gene in melanoma. Constitutive activation of mutant BRAF(V600E) leads to aberrant Ras-independent MAPK signaling and cell transformation. Inhibition of mutant BRAF is a current frontline therapy for such cases, with improved survival compared with chemotherapy. Un...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neoplasia
Autors principals: Mologni, Luca, Costanza, Mariantonia, Sharma, Geeta Geeta, Viltadi, Michela, Massimino, Luca, Citterio, Stefania, Purgante, Stefania, Raman, Hima, Pirola, Alessandra, Zucchetti, Massimo, Piazza, Rocco, Gambacorti-Passerini, Carlo
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2018
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915992/
https://ncbi.nlm.nih.gov/pubmed/29605720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2018.02.009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars